BRIEF published on 03/31/2026 at 13:12, 24 days 4 hours ago Poxel sells the PXL770 to Scynexis for a potential value of $196 million Financial Agreement Poxel PXL770 SCYNEXIS Polycystic Kidney Disease
BRIEF published on 03/31/2026 at 13:12, 24 days 4 hours ago Poxel Sells PXL770 to Scynexis for Up to $196 Million Biopharmaceutical Poxel PXL770 SCYNEXIS ADPKD
PRESS RELEASE published on 03/31/2026 at 13:07, 24 days 4 hours ago Inside Information / Operations of the issuer (acquisitions, sales...) Poxel announces sale of PXL770 for up to $196 million to SCYNEXIS. PXL770 targets ADPKD. Agreement includes upfront payment, development and commercial milestones. Phase 2 study planned for Q4 2026 Milestones Poxel PXL770 SCYNEXIS ADPKD
BRIEF published on 03/25/2026 at 22:03, 29 days 20 hours ago Poxel Secures Additional Financing Through New Tranche D PDR Bonds Financing Continuation Plan Poxel IPF Partners Tranche D PDR
PRESS RELEASE published on 03/25/2026 at 21:58, 29 days 20 hours ago Inside Information / News release on accounts, results Poxel confirms drawdown under Tranche D PDR bond issue for €3.75 million with IPF as part of continuation plan validated by Lyon Commercial Court. Key details and financing prospects outlined Financing Opportunities Poxel IPF Partners Tranche D PDR
BRIEF published on 02/03/2026 at 08:45, 2 months 21 days ago Poxel Establishes Equity Line with IRIS Capital Financing Recovery Plan Equity Line Poxel IRIS Capital
PRESS RELEASE published on 02/03/2026 at 08:40, 2 months 21 days ago Inside Information / Other news releases Poxel announces implementation of equity line with IRIS Capital as part of recovery plan. New financing structure to enhance financial foundation Financial Structure Recovery Plan Equity Line Poxel IRIS Capital
BRIEF published on 01/30/2026 at 08:02, 2 months 25 days ago Commercial Court of Lyon Approves Poxel's Recovery Plan Financial Strategy Recovery Plan Commercial Court Poxel Debts Settlement
PRESS RELEASE published on 01/30/2026 at 07:57, 2 months 25 days ago Inside Information / Other news releases Poxel SA receives approval for recovery plan from Commercial Court of Lyon, closing reorganisation proceedings and focusing on business development, cost optimization, settlement of liabilities, and financial strengthening Business Development Recovery Plan Financial Restructuring Poxel SA Commercial Court Of Lyon
BRIEF published on 12/11/2025 at 19:47, 4 months 12 days ago Poxel Reports Outcomes of General Meeting and Looks Ahead Shareholders General Meeting Biopharmaceutical Recovery Plan Poxel
Published on 04/24/2026 at 15:00, 3 hours 4 minutes ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 15:00, 3 hours 4 minutes ago First Canadian Graphite Appoints Scott Kelly As Chief Financial Officer
Published on 04/24/2026 at 14:30, 3 hours 34 minutes ago Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
Published on 04/24/2026 at 14:00, 4 hours 4 minutes ago Datametrex Expands Patent Monetization Strategy Adding Quantum-Resilient Encryption Technologies
Published on 04/24/2026 at 13:30, 4 hours 34 minutes ago Alset AI Announces Closing of Second Tranche of Loan Transaction of up to $3 Million
Published on 04/24/2026 at 17:45, 19 minutes ago Swiss Life publishes financial condition report – continued strong solvency
Published on 04/24/2026 at 17:45, 19 minutes ago Annual General Meeting of Arbonia AG approves all motions and elects Christoph Ganz as new Chairman of the Board of Directors
Published on 04/24/2026 at 17:21, 43 minutes ago Grand City Properties S.A. announces successful issuance of €600 million perpetual notes and launch of tender offer
Published on 04/24/2026 at 17:18, 45 minutes ago Grand City Properties S.A. announces successful issuance of €600 million perpetual notes and launch of tender offer
Published on 04/24/2026 at 17:08, 55 minutes ago Berliner Effektengesellschaft AG publishes its 2025 separate and consolidated financail statements
Published on 04/24/2026 at 17:45, 19 minutes ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
Published on 04/24/2026 at 16:37, 1 hour 26 minutes ago Availability of the 2025 Universal Registration Document (URD)
Published on 04/23/2026 at 19:27, 22 hours 37 minutes ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 23 hours 45 minutes ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
